BioCatalyst

Elacestrant, Alpelisib, Everolimus, Ribociclib — catalyst calendar

1 verified catalyst event(s) referencing Elacestrant, Alpelisib, Everolimus, Ribociclib, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-27
in 3mo
ESTIMATED
 READOUT
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Vari
Phase 1/2 · Breast Cancer, Metastatic Breast Cancer
 Stemline Therapeutics, Inc. Elacestrant, Alpelisib, Everolimus, Ribo ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.